Searchable abstracts of presentations at key conferences on calcified tissues

ba0002op3 | (1) | ICCBH2013

Calcimimetics as adjunct therapy in XLH: 18 months experience

Alon Uri , Haney Connie

Objective: Based on our preliminary findings, indicating a potential for Cinacalcet (due to its suppression of PTH (CJASN 2008 3 658)), to allow the use of lower doses of oral phosphate (OP) and calcitriol in treating XLH, the objective of this study was to examine its long-term effect as adjunct treatment in children with XLH.Methods: Eight children (F5), ages 7.8–20.9 years (median 13.9), who were already treated by OP an...